Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission

2021; Elsevier BV; Volume: 397; Issue: 10278 Linguagem: Inglês

10.1016/s0140-6736(21)00388-3

ISSN

1474-547X

Autores

Jeffrey D. Sachs, Salim S. Abdool Karim, Lara B. Aknin, Joseph R. Allen, Kirsten Brosbøl, Gabriela Cuevas Barron, Peter Daszak, María Fernanda Espinosa, Ví­tor Gaspar, Alejandro Gaviría, Andy Haines, Peter J. Hotez, Phoebe Koundouri, Felipe Larraín B., Jong‐Koo Lee, Muhammad Ali Pate, Paul Polman, Gabriela Ramos, K. Srinath Reddy, Ismaïl Serageldin, Rajiv Shah, John Thwaites, Vaira Vīķe-Freiberga, Chen Wang, Miriam Were, Lan Xue, Min Zhu, María Elena Bottazzi, Francesca Colombo, George Laryea-Adjei, Yanis Ben Amor, Özge Karadağ Çaman, Guillaume Lafortune, Emma Torres, Ismini Ethridge, Juliana G E Bartels,

Tópico(s)

Viral Infections and Outbreaks Research

Resumo

The Lancet COVID-19 Commission calls for three urgent actions in the COVID-19 response (our broader overview is available on our website). First, all regions with high rates of new COVID-19 cases, including the USA and the European Union (EU), should intensify measures to minimise community transmission alongside rapid deployment of COVID-19 vaccines. Second, governments should urgently and fully fund WHO and the Access to COVID-19 Tools (ACT) Accelerator,1 including COVAX. Third, the G20 countries should empower the International Monetary Fund (IMF) and multilateral development banks to increase the scale of financing and debt relief.

Referência(s)